Guarding Little Minds: Omega-3 Emulsion Shields Newborn Brains

▴ newborn brain health
The effectiveness of the experimental emulsion may be attributed to its faster absorption into the bloodstream, occurring twice as quickly as the commercial emulsion.

In a groundbreaking study, researchers at Columbia University Vagelos College of Physicians and Surgeons have discovered that an injectable emulsion containing omega-3 fatty acids found in fish oil holds the potential to reduce brain damage in newborn rodents after oxygen deprivation during delivery.

Brain damage due to insufficient oxygen during labor and delivery is a severe complication affecting newborns, with significant implications for their future health. This condition, which impacts one to three out of every 1,000 live newborns in the US, can lead to cerebral palsy, cognitive impairment, epilepsy, pulmonary hypertension, and neurodevelopmental disorders among survivors.

The study's findings also revealed that this novel omega-3 preparation outperformed therapeutic hypothermia, the current standard therapy for oxygen deprivation-related brain damage in newborns. Therapeutic hypothermia, while approved by the FDA, only benefits about 15% of patients and carries the risk of heart and respiratory complications.

Previous research by Professor Richard Deckelbaum at Columbia University has shown that commercially available oral omega-3 supplements, while containing bioactive compounds, take weeks or months to exert their protective effects, making them less suitable for immediate organ protection after injury.

The new diglyceride formulation, however, is expected to facilitate rapid penetration of omega-3 molecules across the blood-brain barrier. Administered to week-old mice and rats with hypoxic brain injury, the experimental emulsion demonstrated a significantly greater reduction in brain damage compared to a commercially available omega-3 injectable emulsion, despite similar dosage levels.

The effectiveness of the experimental emulsion may be attributed to its faster absorption into the bloodstream, occurring twice as quickly as the commercial emulsion.

Notably, animals treated with the new therapy exhibited normal motor coordination and reflexes, indicating preserved neurological function akin to those without brain injuries.

According to Professor Deckelbaum, "The omega-3 diglyceride emulsion not only prevented brain cell death but also preserved neurological function, which is crucial in mitigating the burden of disabilities on both patient well-being and the healthcare system."

The researchers anticipate commencing clinical trials in newborns within two years, with plans to further investigate the therapy's efficacy in preventing central nervous system damage in animals with traumatic brain injury and spinal cord injury. Additionally, they aim to explore its potential applications in other acute injuries and conditions where oxygen deprivation leads to organ damage, such as heart attack and stroke.

Tags : #newborn #babies #brainhealth #omega3 #braindamage #newmom #medicircle

About the Author


Sunny Parayan

Hey there! I'm Sunny, a passionate writer with a strong interest in the healthcare domain! When I'm not typing on my keyboard, I watch shows and listen to music. I hope that through my work, I can make a positive impact on people's lives by helping them live happier and healthier.

View Profile

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

India Joins International Medical Device Regulators Forum: A Leap Toward Global Health CollaborationOctober 05, 2024
The Science of Overeating: Why You Can’t Stop at Just One BiteOctober 05, 2024
The Toxic Truth: How Alcohol Fuels Six Deadly CancersOctober 05, 2024
Lenacapavir: India’s Pharmaceutical Giants to Produce a Twice-a-Year Pill Poised to Rewrite HIV PreventionOctober 04, 2024
Can Ending Smoking by 2050 Really Save 1.2 Million Lives? New Lancet Study RevealsOctober 04, 2024
Colon Cancer Crisis: Why It’s Attacking Younger GenerationsOctober 04, 2024
Eye Health Program for Low-Income Residents Launched in Hingoli, MaharashtraOctober 04, 2024
Are we on the path to end AIDS by 2030?October 03, 2024
TTK Prestige Announces Shubhutsav- A Special Festive Offer, Elevating Home CookingOctober 03, 2024
Tata Soulfull Launches Tata Soulfull Corn Flakes+, With the Goodness of Millets in Every Flake October 03, 2024
The Bitter Truth Behind Sweet Treats: Hidden Cancer Risks in Your Favorite CakesOctober 03, 2024
Ageing Faster Than You Think? Discover How a Simple Cheek Swab Could Save Your LifeOctober 03, 2024
The University of Tasmania invites international student applications for their Tasmanian International ScholarshipOctober 03, 2024
A New Hope for Type 1 Diabetes: Tackling Blood Sugar Drops with Somatostatin BlockersOctober 03, 2024
Prostate Cancer Strikes Young: The Alarming Rise of Aggressive Cases in Men Under 50October 03, 2024
Fleetguard Filters Private Limited (FFPL) Wins Prestigious ‘Iconic Brands of India 2024’ at the This recognition adds to Fleetguard's growing list of accolades, further establishing its position as a leader in the automotive industry. The company remains dedicated to advancing innovation and providing solutions that consistently meet the changing needs of its customers.October 03, 2024
Marico’s Saffola Honey and Pankaj Tripathi Uncover the Secret of Shuddha Honey in its latest TVCOctober 01, 2024
Mr. Piush Srivastava, Head of Marketing and Corporate Communications of Fleetguard Filters Pvt. Ltd, Awarded 'Marketing Maverick' by Dun & Bradstreet October 01, 2024
Chikungunya Strikes Back: The Forgotten Virus Making a Deadly ComebackOctober 01, 2024
The Hidden Cancer Risk in Your Morning Routine: How Poor Oral Hygiene May Be Endangering Your HealthOctober 01, 2024